QUESTIONSThe Emerging Neuroscience of Autism Spectrum Disorders (Brain Research 2010)
Venue: San Diego
Location: San Diego, California, United States
| Event Date/Time: Nov 11, 2010 | End Date/Time: Nov 12, 2010 |
| Early Registration Date: Sep 10, 2010 | |
| Abstract Submission Date: May 28, 2010 |
Report as SpamDescription
A Brain Research Meeting
The Emerging Neuroscience of Autism Spectrum Disorders: Etiologic Insights; Treatment Opportunities
A two-day satellite event prior to the 2010 Society for Neuroscience Annual Meeting
11 – 12 November, 2010
San Diego, CA, USA
This meeting will review current knowledge about the molecular and cellular basis of autism spectrum disorders (ASDs). ASDs, which include autism, Asperger syndrome, Rett syndrome, and pervasive developmental disorder – not otherwise specified, typically present with social and language deficits, in addition to proscribed interests and/or stereotyped behaviors. Behavioral interventions remain the first-line treatment for ASDs and can ameliorate symptoms in some individuals. Molecular genetic approaches have begun to identify chromosomal abnormalities and smaller genetic variants that confer high risk for ASDs. These abnormalities can be explored in model systems and are leading to novel rational therapies. Concurrent studies in patients are identifying systems-level changes that implicate neuronal pathways related to specific symptoms of the ASDs. Leading world experts will review all aspects of current research including the possible causes and current treatments of ASDs at this two-day meeting.
The Emerging Neuroscience of Autism Spectrum Disorders: Etiologic Insights; Treatment Opportunities
A two-day satellite event prior to the 2010 Society for Neuroscience Annual Meeting
11 – 12 November, 2010
San Diego, CA, USA
This meeting will review current knowledge about the molecular and cellular basis of autism spectrum disorders (ASDs). ASDs, which include autism, Asperger syndrome, Rett syndrome, and pervasive developmental disorder – not otherwise specified, typically present with social and language deficits, in addition to proscribed interests and/or stereotyped behaviors. Behavioral interventions remain the first-line treatment for ASDs and can ameliorate symptoms in some individuals. Molecular genetic approaches have begun to identify chromosomal abnormalities and smaller genetic variants that confer high risk for ASDs. These abnormalities can be explored in model systems and are leading to novel rational therapies. Concurrent studies in patients are identifying systems-level changes that implicate neuronal pathways related to specific symptoms of the ASDs. Leading world experts will review all aspects of current research including the possible causes and current treatments of ASDs at this two-day meeting.
